Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Clinical trial NCT05559164 · RECRUITING
Trial details
- NCT number
- NCT05559164
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2026-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.